Washington University School of Medicine in St. LouisImproved stem cell transplantation therapies?Science DailyResearchers in Germany have demonstrated that hematopoietic stem cell (HSC) transplants can be improved by treatments that temporarily preven… Continue reading
News-Medical.netNew human stem cell model could pave way for macular degeneration researchNews-Medical.netA study published in the Proceedings of the National Academy of Sciences is the first to demonstrate hallmarks of macular degeneration in a new hu… Continue reading
The Tidings |
A bioethicist’s take on child cancer treatment that uses gene therapy
The Tidings A genetic modification therapy designed for treating pediatric leukemia has drawn both praise and caution from a Catholic bioethicist, after recently being approved by the Food and Drug Administration. While a “promising” use of gene modification … |
The Tidings |
A bioethicist’s take on child cancer treatment that uses gene therapy …
The Tidings A genetic modification therapy designed for treating pediatric leukemia has drawn both praise and caution from a Catholic bioethicist, after recently being … FDA approves first gene therapy ever in US – WNDU 16WNDU-TV |
Reuters |
FDA widens holds on immunotherapy combination blood cancer trials
Reuters (Reuters) – U.S. health regulators stopped five blood cancer trials testing AstraZeneca Plc’s immunotherapy Imfinzi in combination with Celgene Corp medicines from accepting new patients and halted another study entirely, the companies said on Thursday. Pharmalittle: FDA places hold on Celgene and Bristol trials; AstraZeneca-Amgen asthma drug looks strongSTAT FDA puts Celgene’s multiple cancer trials on holdDaily Mail |
Reuters |
FDA widens holds on immunotherapy combination blood cancer trials
Reuters (Reuters) – U.S. health regulators stopped five blood cancer trials testing AstraZeneca Plc’s immunotherapy Imfinzi in combination with Celgene Corp medicines from accepting new patients and halted another study entirely, the companies said on Thursday. Pharmalittle: FDA places hold on Celgene and Bristol trials; AstraZeneca-Amgen asthma drug looks strongSTAT |